Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.

Area of Science:

• Immunology
• Cellular immunology
• T cell biology

Background:

• Understanding the interplay between innate and adaptive immunity is crucial for developing effective immunotherapies.
• 4-1BB costimulation and Toll-like receptor (TLR) activation are key pathways in immune responses.
• The precise functional consequences of combining these pathways remain incompletely understood.

Purpose of the Study:

• To investigate the combined effects of 4-1BB costimulation and TLR3/TLR4 triggering on CD8 T cell expansion, survival, and function in vivo.
• To elucidate the mechanisms underlying the observed T cell responses.
• To understand the dual role of 4-1BB activation in immunity and autoimmunity.

Main Methods:

• In vivo priming of CD8 T cells with 4-1BB ligation and TLR3/TLR4 agonists.
• Assessment of T cell clonal expansion and survival.
• In vitro recall assays to evaluate T cell function.
• Analysis of CD4 T cell proliferation suppression and the role of transforming growth factor-beta (TGF-β).

Main Results:

• Co-administration of 4-1BB ligation with TLR3 and/or TLR4 ligands significantly augmented CD8 T cell clonal expansion and survival.
• While primed T cells responded normally to in vitro recall, co-priming with 4-1BB impaired this recall response.
• The rescued CD8 T cells exhibited suppressive effects on CD4 T cell proliferation through a TGF-β-dependent mechanism.

Conclusions:

• 4-1BB and TLR ligands promote the survival of effector CD8 T cells with potent suppressive recall capabilities.
• These findings provide mechanistic insight into the dual role of 4-1BB in promoting anti-tumor immunity and preventing autoimmune diseases.
• Targeted manipulation of these pathways could offer novel therapeutic strategies.